BACKGROUND: HATCH score is an established predictor of progression from paroxysmal to persistent atrial fibrillation (AF). The purpose of this study was to determine if HATCH score could predict recurrence after catheter ablation of AF. METHODS: The data of 488 consecutive paroxysmal AF patients who underwent an index circumferential pulmonary veins (PV) ablation were retrospectively analyzed. Of these patients, 250 (51.2%) patients had HATCH score = 0, 185 (37.9%) patients had HATCH score = 1, and 53 (10.9%) patients had HATCH score ≥ 2 (28 patients had HATCH score = 2, 23 patients had HATCH score = 3, and 2 patients had HATCH score = 4). RESULTS: The patients with HATCH score ≥ 2 had significantly larger left atrium size, the largest left ventricular end systolic diameter, and the lowest ejection fraction. After a mean follow-up of (823 ± 532) days, the recurrence rates were 36.4%, 37.8% and 28.3% from the HATCH score = 0, HATCH score = 1 to HATCH score ≥ 2 categories (P = 0.498). Univariate analysis revealed that left atrium size, body mass index, and failure of PV isolation were predictors of AF recurrence. After adjustment for body mass index, left atrial size and PV isolation, the HATCH score was not an independent predictor of recurrence (HR = 0.92, 95% confidence interval = 0.76 - 1.12, P = 0.406) in multivariate analysis. CONCLUSION: HATCH score has no value in prediction of AF recurrence after catheter ablation.
BACKGROUND: HATCH score is an established predictor of progression from paroxysmal to persistent atrial fibrillation (AF). The purpose of this study was to determine if HATCH score could predict recurrence after catheter ablation of AF. METHODS: The data of 488 consecutive paroxysmal AFpatients who underwent an index circumferential pulmonary veins (PV) ablation were retrospectively analyzed. Of these patients, 250 (51.2%) patients had HATCH score = 0, 185 (37.9%) patients had HATCH score = 1, and 53 (10.9%) patients had HATCH score ≥ 2 (28 patients had HATCH score = 2, 23 patients had HATCH score = 3, and 2 patients had HATCH score = 4). RESULTS: The patients with HATCH score ≥ 2 had significantly larger left atrium size, the largest left ventricular end systolic diameter, and the lowest ejection fraction. After a mean follow-up of (823 ± 532) days, the recurrence rates were 36.4%, 37.8% and 28.3% from the HATCH score = 0, HATCH score = 1 to HATCH score ≥ 2 categories (P = 0.498). Univariate analysis revealed that left atrium size, body mass index, and failure of PV isolation were predictors of AF recurrence. After adjustment for body mass index, left atrial size and PV isolation, the HATCH score was not an independent predictor of recurrence (HR = 0.92, 95% confidence interval = 0.76 - 1.12, P = 0.406) in multivariate analysis. CONCLUSION: HATCH score has no value in prediction of AF recurrence after catheter ablation.
Authors: Jelena Kornej; Gerhard Hindricks; M Benjamin Shoemaker; Daniela Husser; Arash Arya; Philipp Sommer; Sascha Rolf; Pablo Saavedra; Arvindh Kanagasundram; S Patrick Whalen; Jay Montgomery; Christopher R Ellis; Dawood Darbar; Andreas Bollmann Journal: Clin Res Cardiol Date: 2015-04-17 Impact factor: 5.460
Authors: Amir Y Shaikh; Nada Esa; William Martin-Doyle; Menhel Kinno; Iryna Nieto; Kevin C Floyd; Clifford Browning; Cynthia Ennis; J Kevin Donahue; Lawrence S Rosenthal; David D McManus Journal: Crit Pathw Cardiol Date: 2015-12
Authors: Nebojša Mujović; Milan Marinković; Nebojša Marković; Alena Shantsila; Gregory Y H Lip; Tatjana S Potpara Journal: Sci Rep Date: 2017-01-20 Impact factor: 4.379
Authors: Judit Simon; Mohammed El Mahdiui; Jeff M Smit; Lili Száraz; Alexander R van Rosendael; Szilvia Herczeg; Emese Zsarnóczay; Anikó Ilona Nagy; Márton Kolossváry; Bálint Szilveszter; Nándor Szegedi; Klaudia Vivien Nagy; Tamás Tahin; László Gellér; Rob J van der Geest; Jeroen J Bax; Pál Maurovich-Horvat; Béla Merkely Journal: Clin Cardiol Date: 2021-11-19 Impact factor: 2.882
Authors: Hai Deng; Ying Bai; Alena Shantsila; Laurent Fauchier; Tatjana S Potpara; Gregory Y H Lip Journal: Clin Res Cardiol Date: 2017-05-30 Impact factor: 5.460